April 19, 2023
The University of Cincinnati is one of 50 nationwide trial sites for a new clinical trial testing a new treatment for status epilepticus, the most severe and deadly form of epilepsy.
April 19, 2023
The University of Cincinnati's Alberto Espay was featured in a MedPage Today article commenting on a recent review that found functional neurological disorder is often misunderstood and needs further recognition and parity in medical education, research and clinical service.
April 20, 2023
The University of Cincinnati's Shana Feibel was featured in a Cincy Magazine article discussing trends in the availability of mental health resources.
March 15, 2023
Local television stations including WINK-TV in Fort Myers, Florida and WGEM-TV in Quincy, Illinois highlighted the University of Cincinnati and Cincinnati Children's Hospital Medical Center's first-in-human trial of FLASH radiotherapy.
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
May 5, 2023
WLWT highlighted the story of Lauralee Wheat, a Cincinnati woman preparing to run the Flying Pig Marathon after successful surgery performed by the University of Cincinnati's Joseph Cheng, MD.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
May 8, 2023
The University of Cincinnati's Jiajie Diao and Yujie Sun led recently published research showing the use of a new cellular probe helped discover new findings about certain cellular processes.
May 9, 2023
The University of Cincinnati's Eva Mistry joined Fox 19's morning show to discuss American Stroke Month.
April 7, 2023
Drug Discovery News highlighted research coauthored by the University of Cincinnati's Timothy Phoenix that found a gene called FOXR2 is abnormally expressed in more than 70% of cancer types sampled and could be a potential target for new treatments.